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OBJECTIVE — To evaluate the effects of two low-fat hypocaloric diets differing in the car-
bohydrate-to-protein ratio, with and without resistance exercise training (RT), on weight loss,
body composition, and cardiovascular disease (CVD) risk outcomes in overweight/obese pa-
tients with type 2 diabetes.
RESEARCH DESIGN AND METHODS — A total of 83 men and women with type 2
diabetes(aged56.17.5years,BMI35.44.6kg/m
2)wererandomlyassignedtoanisocaloric,
energy-restricted diet (female subjects 6 MJ/day, male subjects 7 MJ/day) of either standard
carbohydrate(CON;carbohydrate:protein:fat53:19:26)orhighprotein(HP;43:33:22),withor
without supervised RT (3 days/week) for 16 weeks. Body weight and composition, waist cir-
cumference (WC), and cardiometabolic risk markers were assessed.
RESULTS — Fifty-nineparticipantscompletedthestudy.Therewasasigniﬁcantgroupeffect
(P  0.04) for body weight, fat mass, and WC with the greatest reductions occuring in HPRT
(weight [CON: 8.6  4.6 kg, HP: 9.0  4.8 kg, CONRT: 10.5  5.1 kg, HPRT:
13.8  6.0 kg], fat mass [CON: 6.4  3.4 kg, HP: 6.7  4.0 kg, CONRT: 7.9  3.7
kg,HPRT:11.13.7kg],andWC[CON:8.24.6cm,HP:8.93.9cm,CONRT:
11.3  4.6 cm, HPRT: 13.7  4.6 cm]). There was an overall reduction (P  0.001) in
fat-free mass (2.0  2.3 kg), blood pressure (15/8  10/6 mmHg), glucose (2.1  2.2
mmol/l), insulin (4.7  5.4 mU/l), A1C (1.25  0.94%), triglycerides (0.47  0.81
mmol/l),totalcholesterol(0.670.69mmol/l),andLDLcholesterol(0.370.53mmol/l),
with no difference between groups (P  0.17).
CONCLUSIONS — Anenergy-restrictedHPdietcombinedwithRTachievedgreaterweight
loss and more favorable changes in body composition. All treatments had similar improvements
in glycemic control and CVD risk markers.
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C
aloric restriction and physical activ-
ity are cornerstones of obesity and
type 2 diabetes management (1).
Thesubstitutionofsomedietarycarbohy-
drate for protein in a low-fat (30% total
energy) diet may improve body composi-
tion and cardiovascular disease (CVD)
risk factors including insulin sensitivity,
glycemic control, and blood lipids in
overweight/obese populations, including
patients with type 2 diabetes (2–5). How-
ever, these studies have almost invariably
assessed modiﬁed macronutrient compo-
sitions without the inclusion of any exer-
cise intervention.
Layman et al. (6) showed additive ef-
fects of a high-protein (HP) diet com-
bined with exercise for improving body
composition in healthy overweight/obese
women with greater weight and fat loss
following a lifestyle intervention of exer-
cise plus an HP diet, compared with HP
diet alone or a standard carbohydrate
(CON) diet with or without exercise. A
study by Meckling et al. (7) showed sim-
ilar effects. In both these studies, the ex-
ercise programs used were primarily
aerobicexercisebased,whereasresistance
exercisetraining(RT)maybemoreefﬁca-
cious (8). During weight loss, RT can
maintain and/or increase lean tissue and
improve physical functioning (8), and its
importance for improving glycemic con-
trolinpatientswithtype2diabetesiswell
established (9). Recently, Kerksick et al.
(10) showed greater improvements in
body composition in obese women fol-
lowing a 14-week RT program when car-
bohydrate was substituted with protein.
This suggests that an HP diet combined
with RT may improve weight loss, body
composition, and cardiometabolic risk
factors. However, despite its importance,
no studies have evaluated these effects in
individuals with type 2 diabetes. This
study compared the effects of an energy-
restricted HP diet and an isocaloric “tradi-
tional” CON diet with and without RT on
weight loss, body composition, CVD risk
factors, and glycemic control in patients
with type 2 diabetes. We hypothesized that
HPRT treatment would produce the
greatest improvements on these outcomes.
RESEARCH DESIGN AND
METHODS— A total of 83 over-
weight/obese sedentary men and women
(BMI 35.3  4.5 kg/m
2; aged 55.0  8.4
years) with type 2 diabetes were recruited
by public advertisement (Fig. 1). Partici-
pants were excluded if they had known
proteinuria; had a malignancy; had a his-
tory of liver, kidney, cardiovascular, re-
spiratory, or gastrointestinal disease; had
uncontrolled hypertension; were preg-
nant or lactating; were a smoker; or were
using insulin. Participants with any mus-
culoskeletal injury or joint or peripheral
vascular disease sufﬁcient to impede ex-
ercise or who had participated in regular
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sessions/weekofmoderate/vigorousaero-
bic exercise or one 30-min session/week
of RT) during the 6 months prior to
study were also excluded. Participants
provided written informed consent.
The study was approved by the human
research ethics committees of the Com-
monwealth Scientiﬁc and Industrial Re-
search Organisation (CSIRO) and the
University of Adelaide.
In a parallel study, participants were
blockedmatchedforage,sex,andweight,
then randomized to one of four lifestyle
interventions: an energy-restricted stan-
dard carbohydrate, low-protein, low-fat
dietalone(CON)orwithRT(CONRT);
or an isocaloric higher-protein, moder-
ate-carbohydrate, low-fat diet alone (HP)
or with RT (HPRT) for 16 weeks. At
baseline (week 0) and week 16, partici-
pants attended the CSIRO research clinic
after an overnight fast for assessment. At
the clinic testing visits, height (week 0
only), body weight, blood pressure, waist
circumference (WC), and body composi-
tion were measured before a venous
blood sample was drawn and muscle
strengthwasassessed.Priortotheclinical
assessments, a 24-h urine sample was
collected.
Medications at baseline and changes
throughout the study were documented.
Lipid-lowering and antihypertensive
medications were encouraged to remain
constant throughout the intervention.
Participants were asked not to modify
their lifestyle patterns other than neces-
sary during the intervention to comply
with the study protocol.
Diet interventions
The diets were designed to be isocaloric
with moderate energy restriction
(6,000 kJ/day for women, 7,000 kJ/
dayformen).Theplannedmacronutrient
proﬁle of the CON diet was 53% of total
energy as carbohydrate, 19% (0.7 g  
kg
1   day
1) protein, and 26% fat. The
targetproﬁlefortheHPdietwas43%car-
bohydrate, 33% (1.2 g   kg
1   day
1)
protein, and 22% fat. To facilitate dietary
compliance, detailed dietary advice, meal
planning, and recipe information were
providedatbaselineandevery2weeksby
a qualiﬁed dietitian. Key foods represen-
tative of each diet’s macronutrient proﬁle
(50% total energy) were supplied every
2 weeks. Diets were structured to include
speciﬁc food quantities/weights to ensure
correct macronutrient and energy proﬁle
were achieved. These foods were listed in
a quantitative food record completed
daily by participants. Participants were
asked to weigh and measure their food
using scales provided. Dietary composi-
tion was assessed by a qualiﬁed dietitian
based on the analysis of 7 consecutive
days from the semiquantitative food
record of each 2-week period using a
computerized database (Foodworks Pro-
fessional Edition, version 4, 1998; Xyris
Software, Highgate Hill, Australia). Par-
ticipants who did not complete the food
records were excluded as noncompliers.
Figure 1—Participant ﬂow.
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The CONRT and HPRT group partic-
ipants followed a progressive RT pro-
gram. Eight separate exercises (leg press,
knee extension, chest press, shoulder
press, lat pull down, seated row, triceps
press, and sit-ups) were performed using
weight-stacked machines (Maxim Health
Fitness, Adelaide, Australia), except sit-
ups,on3nonconsecutivedays/week.The
weight loading was set at 70–85% one
repetition maximum (1RM, protocol de-
scribedbelow),determinedforeachexer-
cise at Week 0. This allowed 8–12 reps
to volitional fatigue with two sets per ex-
erciseand1–2minrestbetweensetstobe
performed. Once participants could suc-
cessfully perform two sets of 12 repeti-
tions, the weight load was increased to
maintain the training load. Resistance ex-
ercise training sessions lasted 45 min
and were conducted at the CSIRO gym-
nasium under professional supervision.
Participants completed a training diary,
and if a scheduled session was missed,
they were encouraged to attend a make-
up session as soon as possible.
Outcomes, body weight,
composition, blood pressure, and
muscle strength
Bodymasswasmeasuredusingcalibrated
electronic digital scales (Mercury; AMZ
14,Tokyo,Japan),andbodycomposition
was measured using dual-energy X-ray
absorptiometry (DXA; Lunar Prodigy;
General Electric, Madison, WI) to assess
total body fat mass and total body fat-free
mass (FFM). WC was measured on a hor-
izontalplane2cmproximaltotheupper-
most lateral border of the right iliac crest.
Seated blood pressure was measured us-
ing an automated sphygmomanometer
(DYNAMAP 8100; Criticon, Tampa, FL).
Muscle strength (1RM) was assessed
pre- and postintervention for chest press
and lat pull down according to standard
guidelines (11). 1RM of the other ﬁve
weight-stacked exercises were also as-
sessed in the participants in the exercise
groups at baseline only to set initial train-
ing loads. To determine 1RM, following a
low-intensity warm-up, participants per-
formed four to ﬁve trials (separated by a
2-min resting interval) using varying
moderate-heavy weights to determine the
highest weight that could be lifted with
only one repetition through the full range
of motion with correct technique.
Biochemical analyses
Serum lipids and insulin, plasma glucose,
C-reactive protein (CRP), and creatinine
were measured using standard methods
(12). A1C, measured using high-
performance liquid chromatography, and
24-h urinary urea, creatinine, and albu-
min were assessed at a commercial labo-
ratory (IMVS, Adelaide, Australia).
Creatinine clearance was calculated as
(urine creatinine [mol/l]  urine vol-
ume [ml])/(plasma creatinine [mol/l] 
minutes) and corrected for body surface
area (13).
Statistical analysis
Statistical analyses were performed using
SPSS for Windows (version 17.0; SPSS,
Chicago, IL). Prior to hypothesis testing,
data were examined for normality. Non–
normally distributed variables (insulin,
CRP,andurinaryalbumin)werelogarith-
mically transformed before analysis. Dif-
ferences in baseline characteristics were
compared by one-way ANOVA for con-
tinuous variables and 	
2 tests for cat-
egorical variables. This investigation rep-
resents an efﬁcacy trial to determine the
physiological/metabolic effects of the
treatments. Primary analysis was con-
ducted on participants who completed
the study per protocol. Secondary inten-
tion-to-treat (ITT) analysis was also con-
ductedfortheprimaryoutcomemeasures
(body weight and composition, cardio-
metabolic and glycemic control), in-
cluding participants who completed the
study irrespective to protocol adher-
ence. Changes over time in the groups
were assessed using repeated-measures
ANOVA. The effects of the treatments
on changes were assessed using one-
way ANOVA, with group (CON, HP,
CONRT, and HPRT) as a between-
subject factor. Where there was a signiﬁ-
cant main effect, post hoc tests with
Dunnettadjustmentformultiplecompar-
isonswereperformedtodeterminediffer-
ences between group means compared
with HPRT; based on a prior hypothe-
sis, the HPRT group would achieve
greater changes compared with the other
treatments. Age and sex were included as
covariates. No signiﬁcant effect of sex or
agewasobservedforanyoftheoutcomes.
To compare the magnitude of change be-
tween the two diets (CON and CONRT
versus HP and HPRT) and exercise ver-
sus nonexercise (CON and HP versus
CONRT and HPRT), planned con-
trasts were used in the statistical model.
Pearsoncorrelationcoefﬁcientswereused
to determine the relationships between
variables.Statisticalsigniﬁcancewassetat
P  0.05. Data are means  SD.
RESULTS
Participants
Of 83 randomized participants, 18 with-
drewand6participantswereexcludedfor
dietary noncompliance (failure to com-
plete food records); 59 participants com-
pleted the study per protocol (Fig. 1).
There was no difference between treat-
ment groups, diets, or exercise versus
nonexercise groups in the number of par-
ticipants who withdrew (P  0.34) or
who were excluded (P  0.17). At base-
line, there were no signiﬁcant differences
in age, weight, BMI, A1C, and sex distri-
bution between groups (P  0.12). These
characteristics were also similar between
participants who completed or did not
complete the study (P  0.09), except for
age in which completers were on average
5yearsyounger(completers:aged50.8
10.4 years, dropouts: aged 56.1  7.4
years; P 
 0.02).
Dietary composition and exercise
compliance
Based on the food records, participants
showed good compliance with the pre-
scribed diets (Table 1). Total energy in-
take was similar across treatment groups,
while macronutrient composition was
different between the diet groups; the HP
and HPRT groups consumed signiﬁ-
cantlymoreproteinandlesscarbohydrate
and fat compared with the CON and
CONRTgroups.Therewasasigniﬁcant
diet effect for the urinary urea–to–
creatinine excretion ratio (P 
 0.003),
which decreased in the CON diet groups
(CON: 30.8  8.6 to 26.7  3.8,
CONRT:25.95.1to24.24.0)and
increased in the HP diet groups (HP:
31.1  9.8 to 33.6  11.2, HPRT:
28.3  9.5 to 31.5  7.7), indicating
higher protein intakes in the HP diet
groups.
Compliance with RT was deﬁned as
the number of exercise sessions com-
pleted at the prescribed training loads per
total number of prescribed sessions. All
participantsintheCONRTandHPRT
groupsachievedcompliancewiththepre-
scription (deﬁned as 75% of prescribed
sessions), on average completing 93%
(43.5  4.0 of 47) of the prescribed ses-
sions. There was a signiﬁcant effect of ex-
ercise treatment for 1RM lat pull down
and chest press (P  0.001) such that in-
Wycherley and Associates
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with no change in the diet-only groups
(Table 2), indicating compliance with the
prescribed RT.
Body weight and composition
Overall, body weight was reduced (P 
0.001), with a signiﬁcant group effect
(P 
 0.04), such that HPRT achieved
greatest weight loss (CON: 8.9%, HP:
8.7%, CONRT: 10.0%, HPRT:
12.7%) (Table 2). Post hoc analysis
showed that the greater weight loss in
HPRT was statistically signiﬁcant com-
pared with CON and HP groups (P 
0.05), but compared with CONRT sta-
tistical signiﬁcance was not reached (P 

0.20). Overall, weight loss was not differ-
ent between the two diets (P 
 0.18);
however, the exercise groups (HPRT
and CONRT) lost more weight com-
pared with the diet-only groups (CON
and HP) (dietRT: 12.0  5.7 kg, diet
only:8.84.6kg;P
0.02).ITTanal-
ysis showed a similar weight loss pattern,
albeitthemagnitudeofeffectwasreduced
(CON: 9.4  6.5 kg, HP: 8.0  4.8
kg, CONRT: 10.5  5.1 kg, HPRT:
12.6  6.5 kg; P 
 0.16 group effect).
Similarly, fat mass and WC reduced
inallgroups(P0.001)(Table2),witha
signiﬁcant group effect (P  0.006) such
thatHPRThadgreatestreductions.Post
hocanalysisshowedthatHPRThadsig-
niﬁcantly greater reductions compared
with CON and HP (P  0.02), but com-
pared with CONRT, statistical signiﬁ-
cance was not reached (fat mass: P 

0.06, WC: P 
 0.32). Overall, compared
with the diet-only groups, the exercising
groups had greater reductions in fat mass
(dietRT: 9.6  4.1 kg, diet only:
6.7  3.8 kg; P  0.01) and WC
(dietRT: 12.4  4.7 cm, diet only:
8.5  4.3 cm; P  0.01). Overall, more
fatmasslossoccurredinparticipantscon-
sumingtheHPdiet(9.44.5kg)com-
pared with the CON diet (7.3  3.8 kg;
P
0.06).Therewasanoverallreduction
in FFM (Table 2), with no effect of treat-
ment group (P 
 0.91), diet composition
(P 
 0.80), or exercise participation (P 

0.51). ITT analysis conﬁrmed these re-
sults, with a signiﬁcant group effect evi-
dent for fat mass and WC (P  0.02) but
not for FFM (P 
 0.75).
Cardiometabolic outcomes and
glycemic control
Overall, blood pressure, lipids, glucose,
A1C, and CRP were reduced (P  0.02)
(Table 2) with no difference between
treatmentgroups(P0.37),dietcompo-
sition (P  0.27), or exercise participa-
tion (P  0.21). Insulin concentrations
also decreased (P  0.001) with a differ-
ential (nonsigniﬁcant) effect evident be-
tween treatment groups (P 
 0.11), such
that HPRT experienced approximately
twofold greater reductions compared
with the other groups. No differential in-
sulinresponsebetweendietcompositions
(P 
 0.19) or exercise participation (P 

0.29) were observed. Changes in insulin
weresigniﬁcantlycorrelatedwithchanges
in weight (r 
 0.35, P  0.01) and fat
mass (r 
 0.36, P 
 0.005). ITT analysis
also showed no signiﬁcant differences in
the changes of these parameters between
the groups.
Creatinine clearance and urinary
albumin
Overall, creatinine clearance was reduced
(P0.001)(Table2),withnodifferential
effectbetweentreatments(P
0.68),diet
composition (P 
 0.55), or exercise par-
ticipation (P 
 0.46). At week 0, 45 par-
ticipants (CON diet: 27, HP diet: 18) had
normoalbuminuria (urinary albumin ex-
cretion 20 g/min), and values re-
mainedinthenormoalbuminuriarangeat
week 16, except in 1 participant in the
CON group whose urinary albumin ex-
cretion increased (33.4 g/min) to mi-
croalbuminuria classiﬁcation (urinary
albumin excretion 20–200 g/min). At
baseline,14participants(24%;CONdiet:
n
6,HPdiet:n
8)hadmicroalbumin-
uria; at week 16, 4 participants (CON:
n 
 2, HP: n 
 2) remained in the mi-
croalbuminuriarangeand10participants
decreased to normoalbuminuria classiﬁ-
cation (CON: n 
 4, HP: n 
 6).
Medication changes
A total of 33 participants were on hypo-
glycemic medication at baseline (CON:
n 
 11, HP: n 
 7, CONRT: n 
 10,
HPRT: n 
 5), and during the interven-
tion, medication dose was reduced in 9
participants (CON: n 
 2, HP: n 
 1,
CONRT: n 
 4, HPRT: n 
 2) and
increased in 1 participant in the HP
group. There were no signiﬁcant differ-
ences between the treatment groups. At
baseline, 36 and 29 participants were on
antihypertensive medication (CON: n 

9,HP:n
4,CONRT:n
14,HPRT:
n 
 9) and lipid-lowering medication
(CON: n 
 9, HP: n 
 5, CONRT: n 

9, HPRT: n 
 6), respectively. Follow-
Table 1—Macronutrient composition of the treatment groups
CON HP CONRT HPRT
Treatment
group* Diet†
n 16 12 17 14
Energy (kJ) 6,278  648 6,321  763 6,199  696 6,339  649 0.944 0.62
Carbohydrate (g) 197.4  16.3 176.3  23.7 195.0  21.5 170.0  23.1 0.001 0.001
Carbohydrate (% of energy) 53.6  2.6 47.4  1.6 53.6  3.9 45.5  2.4 0.001 0.001
Protein (g) 68.4  5.9 119.0  7.8 68.0  8.3 117.1  6.7 0.001 0.001
Protein (% of energy) 18.6  0.9 32.3  2.8 18.7  1.3 31.6  2.2 0.001 0.001
Fat (g) 38.5  7.7 30.5  8.2 37.5  9.6 33.7  5.5 0.041 0.01
Fat (% of energy) 22.6  3.0 17.7  3.0 22.3  4.5 19.6  1.9 0.001 0.001
Saturated fat (% of total fat) 34.1  5.5 33.9  5.0 33.2  2.8 34.3  4.3 0.90 0.68
Polyunsaturated fat (% of total fat) 19.8  4.5 22.3  3.6 21.4  4.5 21.0  4.2 0.47 0.39
Monounsaturated fat (% of total fat) 46.1  6.6 43.9  4.1 45.5  5.4 44.8  5.1 0.74 0.32
Diet ﬁber (g) 31.1  2.9 24.7  4.0 30.5  4.4 22.6  4.1 0.001 0.001
Data are means  SD. The treatment groups were a standard carbohydrate, low-protein, low-fat diet alone (CON) or with resistance exercise training (CONRT),
oranisocalorichigher-protein,low-fatdietalone(HP)orwithresistanceexercisetraining(HPRT).*Differencesbetweengroups(one-wayANOVA).†Comparison
of the difference between the diets (CON and CONRT vs. HP and HPRT) (planned contrast).
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energy-restricted standard carbohydrate, low-protein, low-fat diet alone (CON) or with resistance exercise training (CONRT), or an
isocaloric higher-protein, low-fat diet alone (HP) or with resistance exercise training (HPRT)
CON HP CONRT HPRT
P
Time
effect*
Group
effect†
Diet
comparison‡
Exercise
comparison§
n 16 12 17 14
Body weight (kg)
Week 0 97.0  10.6 102.7  15.4 105.0  15.3 107.6  15.5 0.001 0.04 0.18 0.02
Week 16 88.4  11.2 93.7  13.8 94.5  15.4 93.8  13.5
Change 8.6  4.6 9.0  4.8 10.5  5.1 13.8  6.0
BMI (kg/m
2)
Week 0 34.8  4.9 35.6  3.8 34.9  4.9 36.6  5.0 0.001 0.06 0.17 0.03
Week 16 31.7  5.1 32.5  3.1 31.4  4.3 31.9  4.3
Change 3.1  1.6 3.2  1.7 3.5  1.7 4.7  2.1
Total body fat mass (kg)
Week 0 38.5  8.0 40.4  8.4 40.4  10.0 42.9  11.6 0.001 0.006 0.06 0.01
Week 16 32.1  9.5 33.2  6.9 32.3  10.7 31.5  11.6
Change 6.5  3.7¶ 7.1  4.0 8.1  3.8 11.4  3.9
WC (cm)
Week 0 111.3  10.7 114.3  6.8 113.7  8.5 116.2  12.7 0.001 0.006 0.19 0.48
Week 16 103.2  12.8 105.4  6.7 102.4  9.6 102.5  11.8
Change 8.2  4.6¶ 8.9  3.9 11.3  4.6 13.7  4.6
Total FFM (kg)
Week 0 58.5  10.7 62.3  13.0 64.6  12.4 64.7  11.5 0.001 0.91 0.80 0.51
Week 16 56.3  10.6 60.4  13.2 62.2  12.0 62.3  10.7
Change 2.2  1.9 1.9  1.5 2.4  2.5 2.4  3.1
Single repetition bench
press (kg)
Week 0 60.0  18.1 68.5  27.4 67.1  22.4 64.6  25.5 0.01 0.001 0.78 0.001
Week 16 58.1  17.7 66.0  25.1 76.2  23.6 75.5  28.9
Change 1.9  4.8# 2.5  8.0** 9.1  8.5 10.9  8.2
Single repetition lat pull
down (kg)
Week 0 49.8  15.1 56.7  15.4 55.0  14.8 55.7  18.7 0.001 0.001 0.51 0.001
Week 16 50.4  14.9 57.2  15.9 66.2  17.4 65.0  20.7
Change 0.6  4.9# 0.6  3.7¶ 11.2  6.0 9.3  4.9
Systolic blood pressure
(mmHg)
Week 0 137  12 141  11 137  10 138  9 0.001 0.90 0.86 0.943
Week 16 124  11 125  11 122  9 124  9
Change 13  11 16  13 16  7 14  9
Diastolic blood pressure
(mmHg)
Week 0 79  98 3  98 1  87 9  8 0.001 0.49 0.56 0.346
Week 16 72  67 4  97 4  67 2  8
Change 7  6 10  6 8  5 7  6
Plasma glucose (mmol/l)
Week 0 9.2  2.7 9.5  2.9 8.7  3.2 8.2  2.1 0.001 0.90 0.79 0.483
Week 16 7.1  1.0 7.0  1.0 6.8  1.5 6.3  1.0
Change 2.2  2.2 2.5  2.7 1.9  2.3 1.9  1.6
Glycosylated hemoglobin
(%)
Week 0 7.6  1.0 8.0  1.8 7.3  1.4 6.8  1.0 0.001 0.21 0.16 0.179
Week 16 6.4  0.7 6.3  0.9 6.2  1.0 5.6  0.6
Change 1.1  0.6 1.8  1.6 1.1  0.7 1.1  0.7
(continued)
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were reduced in six participants
(CONRT: n 
 4, HPRT: n 
 2) and
increased in 1 participant in the
CONRT group, and 1 participant in the
HPRT group ceased lipid-lowering
medication.
CONCLUSIONS — This study showed
substantial improvements in CVD risk
factors and glycemic control following
lifestyle intervention incorporating a
structured, energy-restricted diet that
occurred independent of macronutrient
composition or participation in a RT
program in sedentary obese patients
withtype2diabetes.TheadditionofRT
increased weight and fat mass loss,
which was further magniﬁed by replac-
ing some dietary carbohydrate with
protein.
TheHPRTgroupexhibitedatleasta
3.3-kg greater weight and fat loss and
21% greater reduction in WC compared
withtheothertreatmentgroups.Previous
studiesinhealthy,overweight/obeseindi-
viduals without type 2 diabetes show
greater reductions in weight and fat mass
of similar magnitude when exercise train-
ing is combined with a hypocaloric HP
diet compared with an isocaloric CON
diet (6,7). The CON diet was designed to
reﬂectstandarddietaryrecommendations
(15–20% of total energy as protein) (1).
The HP diet was designed to achieve pro-
tein intake of 25%, corresponding with
typically prescribed HP diets; it provided
an average protein intake of 1.12 g   kg
1  
day
1. Previous studies show that an HP
diet compared with a CON diet is associ-
ated with greater reductions in fat mass
(5,6). RT also reduces fat mass in obese
individuals, independent of caloric re-
striction(14),suggestingthattheseparate
interventional components of an HP diet
and RT may have contributed to the
greater weight and fat mass losses follow-
ing the HPRT treatment.
Although a signiﬁcant main group ef-
fect was observed, post hoc analysis
showed that greater weight, fat mass, and
WCreductionsintheHPRTgrouponly
reached statistical signiﬁcance compared
with the CON and HP groups but not the
CONRTgroup(P0.06),despitelarge
absolute differences. Nevertheless, the
additional weight and fat losses that oc-
curred when RT was combined with an
HP diet compared with a CON diet rep-
resent moderate to large effect sizes
(0.67–0.85) and are considered clinically
relevantandshowntoproduceimportant
health outcomes (15). Furthermore, clin-
Table 2—Continued
CON HP CONRT HPRT
P
Time
effect*
Group
effect†
Diet
comparison‡
Exercise
comparison§
Serum insulin (mU/l)
Week 0 15.8  10.0 12.4  8.6 12.3  4.8 15.2  8.3 0.001 0.11 0.19 0.289
Week 16 11.8  10.2 9.0  8.0 8.8  3.4 7.2  3.6
Change 4.1  4.2 3.5  2.8 3.4  4.0 7.9  8.1
Triglycerides (mmol/l)
Week 0 2.3  1.3 2.0  1.1 1.6  0.5 1.8  0.7 0.001 0.70 0.91 0.626
Week 16 1.7  1.5 1.6  1.2 1.3  0.5 1.2  0.5
Change 0.6  1.1 0.4  1.0 0.3  0.5 0.5  0.6
Total cholesterol (mmol/l)
Week 0 4.8  1.0 5.0  1.1 4.3  0.9 4.7  0.9 0.001 0.89 0.54 0.628
Week 16 4.1  1.1 4.4  1.4 3.5  0.9 4.0  0.8
Change 0.7  0.6 0.6  0.8 0.8  0.9 0.7  0.6
HDL cholesterol (mmol/l)
Week 0 1.2  0.3 1.2  0.3 1.1  0.3 1.1  0.3 0.02 0.86 0.71 0.863
Week 16 1.1  0.3 1.1  0.3 1.0  0.3 1.0  0.2
Change 0.0  0.2 0.1  0.2 0.1  0.2 0.1  0.2
LDL cholesterol (mmol/l)
Week 0 2.7  0.9 2.7  0.9 2.4  0.8 2.7  0.6 0.001 0.37 0.27 0.208
Week 16 2.4  1.0 2.5  1.2 1.9  0.9 2.4  0.6
Change 0.3  0.5 0.2  0.6 0.5  0.6 0.3  0.4
CRP (mgl/l)
Week 0 3.3  2.4 4.5  2.4 3.0  2.6 4.0  2.5 0.001 0.55 0.99 0.183
Week 16 2.6  1.9 3.5  1.1 1.8  1.1 3.0  2.5
Change 0.7  1.5 0.9  1.9 1.2  1.9 1.0  1.9
Creatinine clearance
(ml/min per 1.73 m
2)
Week 0 119.7  22.2 114.3  46.9 116.6  24.4 117.7  24.9 0.001 0.68 0.55 0.46
Week 16 113.1  40.5 96.6  32.1 108.7  22.8 114.2  15.8
Change 6.6  32.0 17.7  37.6 7.9  22.6 5.5  16.4
Data are means  SD. *Changes over time in the groups from weeks 0 to 16 (repeated-measures ANOVA). †Treatment effect between groups for the change from
weeks 0 to 16 (one-way ANOVA). ‡Comparison of the magnitude of change between diets (CON and CONRT vs. HP and HPRT) (planned contrast).
§Comparison of the magnitude of change between exercise and nonexercise treatments (CON and HP vs. CONRT and HPRT) (planned contrast). P  0.05;
¶P  0.01; #P  0.001 signiﬁcantly different from HPRT.
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that WC is an independent predictor of
CVD (16), and the 21% greater reduc-
tions following the HPRT group would
represent a signiﬁcant health improve-
ment. Power analysis estimates that a
sample size of 24 subjects per group
would have been needed for the observed
3.3-kg weight loss difference between the
groups to have been statistically signiﬁ-
cant(80%,P
0.05).Furtherlargerstud-
ies are required to conﬁrm these ﬁndings.
In contrast, Layman et al. (6), who ob-
servedsimilarabsoluteweightandfatloss
differences between treatment groups
comparing CON and HP diets with and
without exercise, achieved statistically
signiﬁcant diet and exercise effects with
smaller sample sizes (n 
 12 per group).
However, this study only examined
women, and sex differences in body com-
position responses to dieting have been
previously observed (5). Although no sex
effects were observed in our study, inclu-
sion of men and women may have in-
creased the data variability, subsequently
lowering the statistical power.
Mechanisms underlying the greater
weight and fat changes in HPRT are not
clear. Given that both diets were isoca-
loricandparticipantsundertookthesame
RT program under controlled conditions,
itsuggeststhesechangesreﬂectmetabolic
differences. The HPRT group experi-
enced approximately twofold greater re-
ductionsinfastinginsulincomparedwith
the other treatments, although, again,
power was not sufﬁcient to reveal signiﬁ-
cantdifferences.Nevertheless,therewasa
signiﬁcant correlation between the
changes in weight and fat mass and insu-
lin levels. Insulin has fat-sparing effects
and promotes adipose tissue accumula-
tion (17). Hence, greater insulin reduc-
tions in the HPRT group may explain
the greater fat mass reductions; however,
causation cannot be determined. Other
evidence suggests that fat mass accumu-
lationdrivesinsulinresistance(17).Alter-
nately, fat has more positive effects on
energy balance compared with other ma-
cronutrients (18). Therefore, although
unlikely, the possibility that lower fat in-
takes in the HP diet contributed greater
fat reductions in the HPexercise group
cannot be dismissed.
In the exercising groups, high com-
pliance with the RT program achieved
substantial strength gains, which is asso-
ciated with metabolic disease reductions
(19). Nevertheless, FFM reduced simi-
larly across treatment groups. Although
previousstudieshaveobservedprotective
effectsofRT(20)andHPdiets(3)onFFM
during caloric restriction, these effects
havenotbeenconsistentlyshown(5),and
perhaps even higher relative protein in-
takes are required. Compared with this
study, experiments demonstrating FFM
preservation following a hypocaloric HP
diet with RT (6,21) administered higher
relative protein intakes (1.12 vs. 1.4 g  
kg
1   day
1). A meta-analysis showed
that the degree of FFM retention during
weight loss increases with increasing
quartiles of protein intake (2), suggesting
thatrelativeproteinintakesmaybeanim-
portant weight loss program design
consideration.
Substantial reductions in CVD risk
markers and glycemic control occurred
during the intervention with no observ-
able differences between the groups. Pre-
vious studies report that RT (14) and HP
diets (22) improve A1C independent of
weight loss in type 2 diabetic patients.
The lack of any difference in glycemic
control between the treatment groups in
the present study may therefore be due to
thehypoglycemiceffectsofenergyrestric-
tion (23), masking any potential effects of
exercise or diet composition. Under
milder energy restriction, RT has been
showntoprovideadditionalreductionsin
A1C (9). Longer-term studies are re-
quired to separate out these effects. Nev-
ertheless, the overall A1C reductions
observed is clinically relevant and associ-
ated with a 21% reduction in diabetes-
related mortality (24).
HP diets having potentially adverse
effects on renal function remains a con-
cern (25). However, no differences in
creatinine clearance or presence of mi-
croalbuminuria between the diets groups
were observed. Other short-term, inter-
ventional studies also report no differ-
ences in renal function in obese
individualswithtype2diabetesfollowing
either an HP or low-protein diet (5,22).
This suggests that a hypocaloric HP diet
doesnotadverselyaffectrenalfunction,at
leastovertheshortterm,insubjectswith-
outovertrenalimpairment.Nevertheless,
diabetes is associated with impaired renal
function, and the longer-term effects in
this patient population warrants further
investigation.
Although not statistically signiﬁcant,
higher participant withdrawals/exclusions
intheHPdietgroupsarenoteworthy.The
exact reason/s are not entirely clear, but
this is not consistent with previous stud-
ies comparing HP versus CON diets that
report similar dropouts with both dietary
treatments and in some studies lower
dropouts following the HP diet (5,7).
In conclusion, participation in RT
produced greater weight and fat loss and
increases in muscular strength compared
with energy restriction alone. Addition-
ally, replacement of some carbohydrate
for protein further magniﬁed these ef-
fects, resulting in greatest reductions in
weight, fat mass, WC, and insulin. All
treatments had similar improvements in
glycemiccontrolandCVDrisk.Alifestyle
modiﬁcation program combining an en-
ergy-restricted HP diet and RT appears to
be a preferred treatment strategy in over-
weight/obese individuals with type 2 dia-
betes. Further studies should evaluate the
longer-term effects.
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